Article PDF
References
Brooks, P.C. et al. 1994 Cell 79: 1157–1164.
Pasqualini, R., Koivunen, E., Ruoslahti, E. 1997. Nature Biotechnology 15: 542–546.
Denekamp, J. 1990. Cancer Metast. Rev. 3: 267–282.
O'Reilly, M.S. et al. 1997. Cell 88: 277–285.
Ingter, D.E. 1997. Discovery of TNP-470 and other angiogenesis inhibitors, in Cancer Therapeutics: Experimental and Clinical Agents. Teicher, B. (ed.). Humana Press, Totowa, NJ.
Huang, X. et al. 1997. Science 275: 547–550.
Kerbel, R.S. 1991. BioEssays 1331–36.
Belotti, D. 1996. Clin. CancerRes. 2: 1843–1849.
Gasparini, G. 1996. Eur. J. Cancer 32A: 2485–2493.
Esserman, L., Weidner, N., Yassa, L., Hylron, N. 1996. Proc. Am. Soc. Clin. Oncol, 15: 129.
Singh, R.K., Gutman, M., Bucana, C.D., Sanchez, R., llansa, N., Fidler, I.J. 1995. Proc. Natl. Acad. Sci. USA 92: 4562–4566.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Folkman, J. Addressing tumor blood vessels. Nat Biotechnol 15, 510 (1997). https://doi.org/10.1038/nbt0697-510
Issue Date:
DOI: https://doi.org/10.1038/nbt0697-510
This article is cited by
-
Phase I study of aflibercept in combination with docetaxel in Japanese patients with advanced solid malignancies
Investigational New Drugs (2022)
-
The extracellular matrix protein mindin attenuates colon cancer progression by blocking angiogenesis via Egr-1-mediated regulation
Oncogene (2018)
-
A phase I and pharmacokinetic study of afilbercept with FOLFIRI: comparison of Chinese and Caucasian populations
Investigational New Drugs (2017)
-
Population pharmacokinetic analysis of free and bound aflibercept in patients with advanced solid tumors
Cancer Chemotherapy and Pharmacology (2013)
-
Minimally invasive colon resection for malignant colonic conditions is associated with a transient early increase in plasma sVEGFR1 and a decrease in sVEGFR2 levels after surgery
Surgical Endoscopy (2010)